Venetoclax with dexamethasone for previously treated relapsed/refractory multiple myeloma


featured image

Venetoclax with dexamethasone is currently in clinical development for the treatment of patients with multiple myeloma (MM). MM, also known as myeloma, is a type of bone marrow cancer.

Indications: Multiple myeloma (MM)
Year: 2021

Venetoclax with dexamethasone is currently in clinical development for the treatment of patients with multiple myeloma (MM). MM, also known as myeloma, is a type of bone marrow cancer. Bone marrow is the spongy tissue at the centre of some bones that produces the body's blood cells. It is called MM as the cancer often affects several areas of the body, such as the spine, skull, pelvis and ribs. MM is currently incurable, and patients tend to go into remission and relapse several times, often needing new or different kinds of treatment than previously received when relapse occurs, therefore, there is a need for new treatments.